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Shape memory polymers (SMPs) are morphologically responsive materials with potential for 
a variety of biomedical applications, particularly as devices for minimally invasive surgery 
and the delivery of therapeutics and cells for tissue engineering, applications which are the 
focus of this Research News article. A brief introduction to SMPs is followed by a discussion 
of the scientific community’s progress towards the development of SMP-based biomaterials 
for clinically relevant biomedical applications.  
1. Introduction 
Shape-memory polymer (SMP)-based materials exist in a ‘memorized’ macroscopic shape, 
temporarily exist in another shape and then revert to their original shape upon exposure to a 
stimulus. These exciting properties render them attractive for a variety of applications in both 
technical industries (e.g. aeronautics, electronics, textiles) and biomedical industries (e.g. 
stents, and scaffolds for the delivery of therapeutics and cells).
[1]
 
The application of SMP-based materials for biomedical applications was pioneered by 
Lendlein and Langer, who first described biodegradable temperature-responsive SMP sutures 
that tightened and sealed a wound upon the application of heat (41°C), as demonstrated in a 
rat model (Figure 1).
[2]
 Their work and the emerging work of others has inspired this Research 
News article. 
 
Figure 1. Degradable shape-memory suture for wound closure. The photo series from the animal experiment 
shows (left to right) the shrinkage of the fiber with increasing temperature. Reproduced with permission.
[3]
 





The unique morphologically responsive nature of SMP-based materials has the potential to 
facilitate their application in novel biomedical settings, particularly as devices for minimally 
invasive surgery, for the delivery of therapeutics and cells and as responsive ‘smart’ 
implantable devices. Indeed, by comparison with traditional materials used in medical 
technologies (e.g. ceramics, metals, polymers) that are morphologically static, SMPs offer a 
number of potential advantages, the clearest being a significant change in morphology 
following deployment by simple surgical procedures as exemplified by the work of Lendein 
and Langer highlighted above. Critically, it can be inferred that SMP devices may be 
implanted as a simple or densely packed structure which when subjected to a physiological 
environment will adopt a complex functional three-dimensional morphology. With the 
alarming rise of antibiotic resistant strains of bacteria that may render previously treatable 
infections deadly, the importance of simple surgical procedures cannot be overstated both in 
the developed and developing world, and SMPs offer a means to radically reduce the 
frequency and severity of infections through the use of keyhole surgery to implant them. 
The unique chemical space that SMPs populate offers chemists and chemical engineers 
significant opportunities to tune their properties to suit a specific application, and many years 
of fundamental research into this class of polymers has yielded fundamental insight into the 
structure-function relationships underpinning their function. Indeed, the structure of the 
polymer backbone plays an important role in SMP hierarchical assembly in 3D, the polymer 
crosslinking (i.e. chemical/physical crosslinks), and therefore the reversibility and timescale 
of any shape switching events. Medical SMPs can be engineered to respond to various 
physiological stimuli (e.g. chemical, electromagnetic, temperature etc.) that result in a 
physicochemical response of the SMP (i.e. changes in chemical structure, degree of 
crosslinking and fraction of amorphous/crystalline domains), which can be tailored to produce 
application-specific changes in polymer morphology. Moreover, the material formulation 




applications. The excitement that these materials have generated has given rise to a large body 
of literature (including some systematic studies) of stimuli-responsive SMP-based materials 
derived from a variety of non-biodegradable and biodegradable polymers (most commonly 
those that respond to temperature), and we direct interested readers towards a series of 
excellent reviews of the subject matter.
[3]
  
While a comprehensive review of SMP chemistry (i.e. molecular requirements, mechanism of 
function, synthesis, their programming, characterization, modeling)
[3]
 is outside the scope of 
this article, an overview of the stimuli to which SMPs respond may serve to spur their further 
development for biomedical applications. While the most commonly employed trigger for 
shape-memory switching is temperature (directly or indirectly applied), it is noteworthy that 
not all SMPs are body temperature-responsive. In cases where the temperature response of the 
SMP is above body temperature (e.g.MM5520 thermoplastic polyurethane) it is possible to 
trigger their shape memory reversion with photothermal excitation as demonstrated for SMP-
based stents;
[4]
 the photothermal shape memory response has also been demonstrated with 
SMPs composites containing gold nanorods as SMP-based sutures, where light-induced 
heating of the nanorods triggers the SMP-based sutures to change shape and close a wound.
[5]
 
Other triggers employed in SMP-based materials include: solvent-polymer interactions (e.g. 
rehydration), electricity, light (e.g. photoisomerization), magnetism, sound, or indeed 
chemical stimuli that utilize redox switches, or reversible/dynamic covalent bonds (e.g. 
acylhydrazones, disulfides) and non-covalent bonds (e.g. supramolecular interactions, 
hydrogen bonds) engineered into the polymers.
[3]
 Clearly, the successful translation of SMP-
based materials from the laboratory to the clinic relies on their ability to respond to 
biocompatible triggering events, and examples of progress in this direction are highlighted 
below. 
 




2.1. SMP-based stents 
Stents based on temperature-responsive polyurethanes (and drugs with undisclosed structures) 
were some of the earliest examples of SMP-based medical devices studied in vitro, wherein 
the shape memory of these materials exhibited at body temperature could help to fix a device 
in place in vivo.
[6]
 The first examples of fully biodegradable body temperature-responsive 
SMP stents were based on poly(L-lactic acid) (PLLA) and poly(glycolic acid) (PLGA) 
bilayers.
[7]
 Stents based on shape memory copolymers (with blocks of polycaprolactone and a 
microbial polyester) showed complete self-expansion at body temperature within 25 
seconds.
[8]
 Stents based on poly(t-butyl acrylate) crosslinked with poly(ethylene glycol) 
dimethacrylate were shown to be body temperature responsive; and the time for full recovery 
(1-10 minutes) from storage at room temperature could be controlled by tuning the crosslink 
density of the polymer and porosity of the stent.
[9]
 SMPs that respond swiftly to temperature 
changes have been shown to decrease surgery times from minutes to seconds for certain 
minimally invasive surgical procedures; as demonstrated using SMPs (copolymers of t-butyl 
acrylate and n-butyl acrylate crosslinked with poly(ethylene glycol) dimethacrylate) that were 
coated on poly(ethylene terephthalate) meshes and delivered laparoscopically in vivo in a pig 
model, reinforcing the importance of developing such swiftly responding materials.
[10]
 
Analogous SMP-coated meshes implanted in rats were shown to deter the 
infiltration/migration of inflammatory cells and fibroblasts relative to uncoated poly(ethylene 
terephthalate) meshes because the interstitial space in spaces in the poly(ethylene 
terephthalate) meshes was not patent, resulting in the deposition of less collagenous scar 




Critically, responsive stents that prevent/deter restenosis (narrowing of blood vessels after 
surgical interventions) are a significant focus of SMP technology. Examples of SMP-derived 




antiproliferative and immune suppressive properties),
[12]
 or paclitaxel (an antiproliferative that 
limits the growth of neointima)
[13]
 over a period of weeks. Interestingly, temperature-
responsive SMP-based stents that elute curcumin (an antiproliferative and anticoagulant) and 
mitomycin C (an inhibitor of smooth muscle cell proliferation and neointima formation) over 
14 and 60 days, respectively, were shown to simultaneously inhibit early thrombosis and long 




A particularly interesting example of a body-temperature-responsive SMP-based stent is 
intended for use in patients suffering from esophageal stricture (sometimes induced by cancer 
or trauma), based on a copolymer of poly(caprolactone-co-DL-lactide). Such SMP-based 
stents have prospects for the replacement of metal alloy-based stents displaying shape 
memory properties because their mechanical properties are closer to those of the tissue in 
which they are implanted, and preclinical experiments using dogs have successfully 
demonstrated their potential advantage over traditional metallic devices.
[15]
  
2.2. SMP-based materials with speculative application as medical devices 
As noted above, the presence of microbes on implant surfaces can cause life-threatening 
infections (particularly with the alarming rise in prevalence of antimicrobial resistant strains). 
Consequently, a variety of SMP-based devices have been developed, some of which display 
antimicrobial activity. Indeed, SMPs loaded with Fe3O4 nanoparticles (which can trigger 
shape-memory effects through inductive heating)
[16]
 were shown to display antimicrobial 
activity towards Staphylococcus aureus and Klebsiella pneumoniae,
[17]
 and SMPs loaded with 
silver nanoparticles were also shown to display antimicrobial activity towards Pseudomonas 
aeruginosa and Staphylococcus aureus.
[18]
 
Therapeutic embolization entails deliberately blocking a blood vessel (e.g. clipping an 
aneurysm to prevent internal bleeding, or reducing/stopping blood flow to tumors), and body 




cytocompatible and enable the infiltration of mouse L929 fibroblast cells in vitro which is 
promising for potential future applications as aneurysm fillers in vivo.
[19]
 Different 
temperature-responsive polyurethane SMPs that responded to temperature by expanding up to 
70 times their original volume were shown to be relatively non-immunogenic in vitro
[20]
 and 
after 90 days of implantation of radio-opaque analogues in a pig aneurysm model these 




3. SMP-based drug delivery devices 
3.1. SMP-based hydrogels as drug delivery devices 
Hydrogels are widely used in drug delivery because of their tunable compositions, 
crosslinking densities, and the molecular weight distribution of drugs that can be delivered in 
a controlled manner. One of the earliest examples of SMP-based devices designed for drug 
delivery was reported by Uragami and coworkers.
[22]
 Non-biodegradable polyacrylamide 
hydrogels incorporating supramolecular crosslinks formed through the specific interaction of 
an antibody and antigen attached to the backbone of the polyacrylamide chains were observed 
to swell upon the addition of competitive antigen to the hydrogel, enabling the delivery of a 
high molecular weight model drug (hemoglobin, 68 kDa) from the hydrogel matrix within a 
few hours.
[22]
 Supramolecular polymer-based hydrogels displaying pH-responsive SMP 
properties, have also been developed to allow the passive diffusion of anionic species at low 
pH (3.2) and the delivery of cationic species, triggered by an increase in pH (to 6.2).
[23]
 
Alternatively, shape memory coatings for model drug-loaded hydrogels have been 
demonstrated to be effective for inducing hydrogel-medicated drug delivery resulting from the 
stress induced by the shape memory outer layer following an increase in temperature.
[24]
 
Hydration-responsive SMP-based materials enable the delivery of drugs and potentially cells 
to a precise location inside the body by minimally invasive surgical procedures. For example, 




(e.g. glucose, sucrose, lactose, polyethylene glycol, sodium chloride) have been shown to 
respond to rehydration by releasing a model low molecular weight drug azorubine over a 
period of hours.
[25]
 Furthermore, macroporous alginate hydrogel scaffolds were introduced 
into immunocompromised mice through a small catheter, and were rehydrated in situ with a 
suspension of cells (primary bovine articular chondrocytes) or cell-free medium delivered 
through the same catheter. The scaffolds typically recovered their original shape and size 
within one hour of implantation, maintained the structure of the original scaffold after 2 
months and appeared histologically stable after 6 months in vivo.
[26]
 Analogous alginate-
based scaffolds were also shown to allow the adhesion and growth of stem cells in vitro, and 
to be capable of controlled release of insulin-like growth factor-1
[27]
 or macromolecular model 
drugs in vivo when implanted subcutaneously in a mouse model.
[28]
 
3.2. SMP-based materials with speculative application as drug delivery devices 
SMP-based particulate systems are also being widely explored, for drug delivery applications 
in vivo. Indeed, temperature-responsive biodegradable poly(DL-lactic acid)-based particles 
are capable of delivering the low molecular weight drug theophylline.
[29]
 More recently, 
temperature-responsive particles composed of biodegradable copolymers of poly(ω-
pentadecalactone) and polycaprolactone have demonstrated the ability to be switched from 
oblate spheroid to prolate spheroid (Figure 2).
[30]
 Analogous temperature-responsive particles 
composed of polycaprolactone and poly(ethylene glycol) have been shown to be 
phagocytosed by macrophages and were subsequently switched from spherical to ellipsoidal. 
In this study the authors suggested that it would be possible to either promote or deter 










Figure 2. SME of micrometer-sized particles. (A) SEM images of particles in their permanent spherical shape 
(left) and programmed prolate ellipsoidal shape (right). (B) Programming of spherical particles (permanent 
shape) embedded in PVA phantoms (l0 = initial length, Δlph = length change during stretching; Δlph·l0
−1
 = εph) to 
their temporary shape and microscopy of temperature induced shape recovery for isolated particles (εph = 100%). 
(C) Shape recovery to non-spherical shape after i) heating to Tmax > Tm,PPDL, stretching (εph = 50%), and cooling 
for defining the new permanent prolate spheroidal shape, and ii) programming in perpendicular direction (εph = 
50%) at Thigh to temporary oblate spheroidal shape. Reproduced with permission.
[30]
 Copyright 2014, Wiley.  
 
Temperature-responsive composites-based on polycaprolactone and poly(sebacic anhydride), 
have been shown to be capable of delivering paracetamol (5 weight % loading) by passive 
diffusion while maintaining their SMP properties,
[32]
 and ultrasound-responsive SMP-based 
drug delivery devices have been developed for the delivery of copper sulfate (formerly used 
as an emetic and antimalarial),
[31]
 or a high molecular weight model drug (lysozyme),
[33]
 




Lendlein and coworkers have made some interesting contributions to the literature with 
temperature-responsive degradable caprolactone-based polymers for the delivery of 
hydrophilic drugs (such as ethacridine lactate) and hydrophobic drugs (e.g. Enoxacin).
[35]
 
They further developed these systems to act as implantable devices with body temperature 
induced shape change (potentially enabling immobilization in a fixed location in a patient), 
enabling the delivery of ethacridine lactate, Enoxacin and Nitrofurantoin,
[36]
 and these 
systems were shown to slowly degrade over the period of weeks when implanted in rats.
[37]
 
Subsequently, other researchers have manufactured body temperature responsive SMP device 
that immobilized a drug delivery device, for the delivery of model macromolecular drugs to 








4.1. Generic SMP-based tissue scaffolds 
SMP-based tissue scaffolds potentially enable their implantation via minimally-invasive 
surgical techniques, and are of broad applicability in the body, with examples of both soft and 
hard tissue scaffolds having been reported. The ubiquity of fibroblasts makes them very 
popular for preliminary in vitro studies on SMP-based materials. Indeed, Lendlein and 
Langer’s biodegradable temperature-responsive SMPs that were used as sutures for wounds[2] 
were shown to support the adhesion and proliferation of mouse fibroblast NIH 3T3 cells over 
a period of one week,
[39]
 and films composed of temperature-responsive poly(glycerol-co-
dodecanoate) SMPs have been shown to support the adhesion and proliferation of human 
fibroblast cells over a period of three weeks.
[40]
 Studies involving stem cells and temperature-
responsive SMPs based on polycaprolactone have been shown to support the adhesion and 
proliferation of human bone marrow-derived stem cells over a period of 3 days.
[41]
 More 
advanced studies have focused on the development of biomaterials with higher technology 
readiness levels tend to include in vivo studies in small mammals. For example, temperature-
responsive potato starch-derived SMP-based fibers implanted in a rat model exhibited normal 
tissue integration with a low inflammatory response after 8 days.
[42]
 Interestingly, 
biodegradable temperature-responsive SMPs based on copolymers of polyhedral oligomeric 
silsesquioxane and poly(D,L-lactide) implanted subcutaneously in a rat model elicited a mild 
foreign body type immune response, their degradation rates inversely correlated with the 
length of the poly(D,L-lactide) chains, and one year after implantation no pathologic 
abnormities were detected from the vital/scavenger organs examined, highlighting their 
promise for scaffold-assisted tissue repair.
[43]
  
4.2. Instructive SMP-based tissue scaffolds 
Tissue scaffolds that instruct cell behaviour represent a significant focus of current tissue 
engineering strategies.
[44]
 Films composed of temperature-responsive caprolactone-based 




cells over a period of one week.
[45]
 Subsequent studies on similar temperature-responsive 
caprolactone-based SMPs have reported the adhesion and proliferation of mouse fibroblast 
L929 cells, rat mesothelial cells, human mesothelial cells and human mesenchymal stem cells 
on the materials for up to 3 weeks. However, activation of the shape memory effect by 
heating to 54
°
C was shown to affect L929 cell adhesion and induce apoptosis (although not 
necrosis). Control studies showed that these effects was not through cellular exposure to 
elevated temperature, but were rather related to the shape change process,
[46]
 which may 
provide mechanical stimulation to prevent adhesion or promote cell death. Body temperature-
responsive SMP-based materials that are programmed to change surface topography can also 
be used to control cell morphology. Indeed, films with micrometer-scale grooves that act as 
topographical cues have been explored as active materials to induce mouse embryonic 
fibroblasts to alignment. These SMP substrates can be switched from anisotropic topographies 
to induce contact guidance to flat featureless surface wherein loss of the topographical cue 
leads to a decrease in cell alignment (as evidenced by an increase in angular dispersion while 
maintaining cell viability);
[47]
 an analogous effect is observed for human adipose-derived stem 
cells that align on aligned electrospun SMP fibers and lose their alignment after the scaffold is 
triggered to switch to unaligned fibers.
[48]
 Elegant experiments showed that SMP-based films 
with micrometer-scale grooves programmed to switch their alignment by 90
°
 induced mouse 
fibroblast NIH 3T3 cells to realign with the grooves over the period of 48 hours.
[49]
 
Furthermore, analogous systems with grooves with switchable widths have been employed to 
apply mechanical force to regulate the shape and the cytoskeletal arrangement of rat stem 
cells, thereby coaxing lineage-specific differentiation of the stem cell towards myogenic 
lineages in the absence of any induction factors.
[50]
 Taken together, this hints that SMP 
topographies may play important future roles in smart, tissue engineered implants, or lab-on-
chip devices.  




Lendlein’s group have further developed SMP-based materials for vascular tissue 
regeneration, studying a variety of SMPs, and exploring processing parameters for the 
fabrication of various material formulations. Their studies have employed block copolymer 
SMPs based on poly(p-dioxanone)diol and poly(ɛ-caprolactone)diol (PDCs), which have been 
shown to enable adhesion of endothelial cells,
[51]
 to be hemocompatible to capillary 
endothelial cells in the chorioallantois membrane (CAM) test,
[51]
 and to be angiogenic.
[51, 52]
 
When compared to polypropylene (widely used for blood-contacting medical devices such as 
blood oxygenators and dialysis tubes), protein adsorption studies showed higher amounts of 
blood plasma proteins adsorbed on PDC.
[53]
 Plasma kallikrein synthesis was unchanged on 
PDC and polypropylene, however, platelet adhesion on PDC materials was markedly lower 




4.4. SMP-based bone tissue scaffolds 
The development of SMP-based bone-tissue scaffolds has become a focus of recent research 
due to the discovery of responsive bioglass formulations and polymeric nanocoposites with 
high compression resistance. The benefit of SMP in orthopedic applications stem from an 
ability of these materials to expand into irregular bone defects to promote fixation and 
regeneration. Interestingly, hydration-responsive chitosan-bioglass composite tissue scaffolds 
have been shown to rapidly fill bone defects in vivo,
[54]
 as have body temperature-responsive 
copolymers of L-lactide/glycolide/trimethylene carbonate or L-lactide/glycolide/e-
caprolactone (Figure 3).
[55]
 Electrospun mats of temperature-responsive biodegradable SMPs 
based on poly(D,L-lactide-co-trimethylene carbonate) have also demonstrated to support rat 
calvarial osteoblast adhesion and proliferation, and functionally promote biomineralization-







Figure 3. Pictures presenting the filling process of bone defect with scaffold no. 1 in model bone tissue defect: 
(A) after few seconds, (B) after 2 min, (C) after 11 min and (D) after 20 min from application. Test was 
performed in water bath at 37
o
C. Reproduced with permission.
[55]
 Copyright 2014, Wiley.  
 
Importantly, temperature-responsive polycaprolactone-based foams (with an optional 
bioactive polydopamine coating) are reported to become malleable when warm and could be 
pressed into an irregular model bone defect, and locked within the defect when cooled. These 
materials promoted adhesion, proliferation, osteogenic gene expression and extracellular 
matrix deposition when cultured with human osteoblasts in vitro.
[57]
 Furthermore, Composite 
materials incorporating hydroxyapatite are commonplace in bone tissue engineering studies, 
and composites of poly(D,L-lactide) and hydroxyapatite have been reported to display 
temperature-responsive shape memory properties.
[58]
 Studies employing temperature-
responsive foams based on composites of polycaprolactone and hydroxyapatite showed that 




cytocompatibility towards rabbit bone marrow-derived stem cells in vitro. Critically, when 
implanted in a rabbit mandibular bone defect this material was shown to promote new bone 





SMP-based materials (Figure 4) represent a novel class of biomaterials with potential for 
biomedical applications including devices employable via minimally invasive surgery or 
devices for the delivery of drugs and cells, as highlighted in this Research News article. 
We see many challenges that first need to be overcome in terms of the development of 
polymer chemistry (e.g. designing polymers that respond to biocompatible triggers, 
potentially even endogenous biological conditions/events); materials processing (e.g. 
obtaining materials with biomimetic mechanical properties and topographical properties); 
biocompatibility (e.g. biodegradation into safe non-toxic byproducts), preclinical testing 
(ideally without the use of animals), and ultimately clinical trials (which requires the 
technology to offer strategic advantages over others on the market at an affordable price). 
We foresee that these materials have strong prospects for clinical translation, particularly 
when attractive multifunctional properties have been engineered into the polymers (e.g. 
biodegradable antimicrobial polymers), however, we believe that such materials have 
prospects for grand healthcare challenges such as the provision of affordable healthcare 





Figure 4. Schematic overview of the shape memory process in nanocomposite polymeric 
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Stimuli-responsive shape memory polymer-based materials have great potential for 
application in a variety of biomedical applications. Their development towards use as 
functional biomedical devices for drug delivery, minimally invasive surgery and tissue 
engineering are the focus of this Research News article, particularly with a view to their 
progress towards clinical relevance. 
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